Related Experiment Videos
O6-Methylguanine-DNA methyltransferase in human cells
Abstract:
O6-Methylguanine-DNA methyltransferase activity was measured in extracts of human tumor cells and was partially purified from human placenta. Repair of O6-methylguanine in DNA inactivated the methyltransferase, and treatment of cells with MNNG, which produces this alkylated base in DNA, depleted the cells of active methyltransferase. RNA and protein synthesis were required for restoration of methyltransferase activity, which transiently exceeded the original levels by 50% 48 h after treatment. One species of methyltransferase of Mr = 22 kd was present in human tumor cells and human placenta.
Insights
O6-methylguanine-DNA methyltransferase repairs DNA damage from alkylating agents. Its activity is depleted by MNNG treatment but restored by RNA and protein synthesis, temporarily increasing beyond original levels.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- DNA repair mechanisms are crucial for maintaining genomic integrity.
- O6-methylguanine-DNA methyltransferase (MGMT) is a key enzyme in protecting against DNA alkylation damage.
- Understanding MGMT's regulation is vital for cancer therapy and toxicology.
Purpose of the Study:
- To investigate the activity and regulation of O6-methylguanine-DNA methyltransferase in human tumor cells and placenta.
- To elucidate the mechanism of MGMT inactivation and reactivation following exposure to alkylating agents.
- To characterize the molecular properties of human MGMT.
Main Methods:
- Measurement of O6-methylguanine-DNA methyltransferase activity in cellular extracts.
- Partial purification of the enzyme from human placenta.
- Treatment of cells with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to induce DNA damage and assess enzyme depletion.
- Monitoring of enzyme activity restoration in the presence and absence of RNA and protein synthesis inhibitors.
Main Results:
- O6-methylguanine-DNA methyltransferase activity was detected in human tumor cells and placenta.
- Enzyme activity was inactivated upon repair of O6-methylguanine in DNA.
- MNNG treatment depleted active methyltransferase levels in cells.
- Restoration of methyltransferase activity required RNA and protein synthesis.
- Activity transiently increased by 50% at 48 hours post-treatment.
- A single species of methyltransferase with a molecular weight of 22 kDa was identified.
Conclusions:
- O6-methylguanine-DNA methyltransferase is inactivated during DNA repair, and its levels are modulated by cellular synthesis.
- The enzyme's activity can be restored and even upregulated following DNA damage, indicating a dynamic regulatory process.
- Human O6-methylguanine-DNA methyltransferase exists as a 22 kDa protein species in both tumor cells and placenta.